Sohail Chaudhry
Vice President, Clinical Development Nektar Therapeutics
Sohail Chaudry, MD, is Vice President of Clinical Development at Nektar Therapeutics and an NIH-trained physician-scientist with over a decade of leadership across clinical development, medical affairs, and translational research. He has led global teams at C-suite level and brings deep experience designing preclinical through Phase I–III trials across immunology, oncology, CNS, infectious and rare diseases. A published author and frequent speaker, Sohail is also a trusted medical-scientific advisor on regulatory and patent strategy.
Seminars
Thursday 21st May 2026
Panel Discussion: Modernising Dermatology Trial Design: Reducing Placebo Noise, Updating Endpoints & Strengthening Site Execution
11:30 am
- Redesigning dermatology endpoints by addressing outdated scales, high placebo response, and the need for validated assessments in understudied diseases where current tools fail to capture meaningful patient change
- Improving trial integrity through stronger site strategy by prioritising dermatology-specific expertise, rigorous site preparation, and high-quality CRO oversight to minimise variability, reduce placebo inflation, and ensure reliable clinical evaluation
- Designing studies that reflect real-world dermatology by incorporating combination therapy considerations, cultural and behavioural adaptations, patient-centred outcomes, and feasible protocols that account for Europe’s fragmented healthcare pathways
